The Menopause Hour - Episode -31
Podcast

The Menopause Hour with Winona: Creams vs. Pills, Safety, and Why the FDA Is Finally Catching Up - Episode #31

Published: December, 2025

Dr. Michael Green

Featured Physician

Michael Green

Host

Inna Gordeyeva

Episode #31 of The Menopause Hour with Winona was a replay of a live Ask the Experts Q&A, hosted by Winona's Ina Gordeyeva and featuring Chief Medical Officer Dr. Michael Green. He opened the show by revisiting the FDA's decision to lift the black box warning on hormone therapy products for menopause.

Dr. Green discussed the difference between HRT creams and pills, compounding standards for progesterone cream for uterine protection, and how oral and transdermal estrogen affect cardiovascular risk differently. He also answered listener questions about DHEA, vaginal dryness, and why hormone lab testing remains an unreliable tool for guiding HRT treatment decisions.


LISTEN TO THE EPISODE

Episode Details

  • Podcast: The Menopause Hour with Winona

  • Episode Number: 31

  • Episode Title: Episode #31: Creams vs. Pills, Safety, and Why the FDA Is Finally Catching Up

  • Host: Inna Gordeyeva

  • Featured Physician: Dr. Michael Green

  • Published Date: December 23, 2025

  • Episode Duration: 1 hour 1 minute

  • Format: Menopause Q&A

  • Main Topics: HRT Cream vs. Pill, FDA Black Box Warning, Compounding Safety

About The Menopause Hour with Winona Podcast

The Menopause Hour with Winona is a health and wellness podcast featuring Winona's Chief Medical Officer Dr. Michael Green and Medical Director Dr. Cathleen Brown. The show addresses common questions about perimenopause and menopause, combining medical expertise with straightforward discussions of symptoms, treatment options, and the science behind the menopause transition.

Episodes include live Q&A sessions, doctor-led conversations, and patient stories. In its live Q&A format, women from Winona's community submit questions directly to the hosts, creating practical discussions shaped by the concerns women commonly bring to their own doctors.

Visit The Menopause Hour on Buzzsprout.

About This Episode

This live Q&A opened with Dr. Michael Green revisiting the FDA's decision to remove the black box warning from hormone therapy products. He described the change as long overdue given how much research has evolved since the warning was first added.

From there, listeners asked whether HRT creams are as safe and effective as oral pills, with Dr. Green explaining how systemic risk is directly influenced by whether hormones undergo processing by the liver.

Several questions focused on trust and safety, including how Winona's compounding pharmacies control the quality of progesterone cream for sufficient protection of the uterine lining.

Other questions centered around why bioidentical progesterone appears safer than the synthetic progestins used in older studies, and how localized estrogen can be used safely alongside systemic HRT for targeted relief from vaginal dryness. Dr. Green also addressed surgical menopause, DHEA dosing, and why hormone testing still doesn't guide how Winona manages treatment.

RSVP here to join our next Menopause Q&A.

Topics Covered

  • Comparing absorption and safety of HRT creams and pills

  • Why oral estrogen may lower cardiovascular risk more than patches or creams

  • How Winona's compounding pharmacies ensure progesterone cream quality

  • Bioidentical versus synthetic progesterone and breast cancer risk

  • Determining what stage of menopause you're in

  • Whether DHEA blood levels matter for supplementation

  • Typical timeline for symptom improvement on HRT

  • Switching between hormone delivery methods: creams, patches, pills

  • Vaginal dryness and combining local and systemic estrogen

  • Surgical menopause after hysterectomy and oophorectomy

  • Why hormone lab testing doesn't guide HRT dosing

  • Taking progesterone daily versus cyclically

Key Takeaways

HRT creams and pills are absorbed differently in the body

Dr. Green explained that oral HRT passes through the liver first, whereas creams are directly absorbed through the skin. Because transdermal methods bypass metabolization by the liver, they carry a more favorable safety profile with regard to blood clots. However, Dr. Green noted that the overall risk difference between the two is small, since the underlying risks are already low for appropriately screened patients.

Progesterone cream only protects the uterine lining when it's compounded and dosed correctly

Dr. Green explained that Winona maintains strict quality control over its compounding pharmacies specifically to ensure consistent dosing and potency of the progesterone cream for adequate uterine protection. He cautioned that not all compounded or over-the-counter progesterone products meet that standard, which can leave the uterus unprotected.

Bioidentical progesterone appears safer than the synthetic progestins linked to breast cancer risk

Dr. Green clarified that older research linking HRT to increased breast cancer risk used a synthetic progestin, not the bioidentical micronized progesterone widely prescribed today. Early data suggests that bioidentical micronized progesterone may not carry the same risk. However, research is still emerging.

Vaginal estrogen can be added to systemic HRT without extra risk

For persistent vaginal dryness that does not fully improve with systemic HRT, Dr. Green noted that vaginal estrogen cream can be used alongside a patch, pill, or body cream. Because the cream works locally on the tissues where it is applied, there is minimal systemic absorption, making it safe to use on its own or as a complement to systemic hormone therapy.

Hormone lab tests don't guide how HRT is dosed

Dr. Green explained that hormone levels fluctuate throughout the day, so a single blood test doesn't fully reflect what's happening in the body hormonally. Winona adjusts treatment based on symptoms, not lab values, the same approach recommended by the American College of Obstetricians and Gynecologists (ACOG) and Menopause Society.


Michael Green

Dr. Michael Green

Obstetrics & Gynecology

Dr. Michael Green is a menopause specialist and Chief Medical Officer at Winona. He brings more than 25 years of clinical experience as a full-scope OB/GYN. From having delivered over 5,000 babies and now specializes in menopause, perimenopause, hormone changes, symptom care, and treatment options during midlife.

At Winona, Dr. Green helps women better understand symptoms, health history, hormone changes, and when physician-reviewed care may be appropriate.

Meet Dr. Michael Green

Watch or Listen to the Episode

Watch the full conversation with Dr. Michael Green on
The Menopause Hour with Winona with Inna Gordeyeva .

Get Physician-Led Menopause Care

Winona helps women access menopause and perimenopause care from home. Start with a short health questionnaire, and a board-certified physician will review your symptoms, health history, and treatment options.

Start Your Visit
lead-banner-woman-holding-mug-mobile